# GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity

> **NCT07668765** · — · NOT_YET_RECRUITING · sponsor: **Gazi University** · enrollment: 100 (estimated)

## Conditions studied

- Morbid Obesity
- Anorectal Diseases
- Drug-Related Side Effects and Adverse Reactions
- Constipation
- Diarrhea

## Interventions

- **DRUG:** GLP-1 receptor agonist therapy

## Key facts

- **NCT ID:** NCT07668765
- **Lead sponsor:** Gazi University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2027-04
- **Final completion:** 2027-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668765, "GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07668765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*